SC 13G | 2024-02-09 | MORGAN STANLEY | Organogenesis Holdings Inc. | 11,505,331 | 8.7% | EDGAR |
SC 13G/A | 2024-02-02 | Soleus Capital Master Fund, L.P. | Organogenesis Holdings Inc. | 8,963,000 | 6.8% | EDGAR |
SC 13G/A | 2023-04-06 | BlackRock Inc. | Organogenesis Holdings Inc. | 4,488,613 | 3.4% | EDGAR |
SC 13G/A | 2023-02-14 | Soleus Capital Master Fund, L.P. | Organogenesis Holdings Inc. | 7,363,063 | 5.6% | EDGAR |
SC 13G/A | 2023-02-10 | Flynn James E | Organogenesis Holdings Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-03 | BlackRock Inc. | Organogenesis Holdings Inc. | 11,103,190 | 8.5% | EDGAR |
SC 13G | 2022-10-13 | Soleus Capital Master Fund, L.P. | Organogenesis Holdings Inc. | 6,626,063 | 5.1% | EDGAR |
SC 13G/A | 2022-02-11 | Flynn James E | Organogenesis Holdings Inc. | 8,456,876 | 6.6% | EDGAR |
SC 13G | 2022-02-04 | BlackRock Inc. | Organogenesis Holdings Inc. | 8,239,832 | 6.4% | EDGAR |
SC 13D/A | 2021-12-30 | Ades Alan A. | Organogenesis Holdings Inc. | 26,375,746 | 20.5% | EDGAR |
SC 13D/A | 2021-12-17 | Ades Alan A. | Organogenesis Holdings Inc. | 26,375,746 | 20.5% | EDGAR |
SC 13G | 2021-07-09 | Flynn James E | Organogenesis Holdings Inc. | 7,694,363 | 6.0% | EDGAR |
SC 13D/A | 2021-06-01 | Ades Alan A. | Organogenesis Holdings Inc. | 26,375,746 | 20.6% | EDGAR |
SC 13D/A | 2021-05-27 | Avista Acquisition Corp. | Organogenesis Holdings Inc. | 0 | 0.0% | EDGAR |
SC 13D/A | 2021-05-18 | Avista Acquisition Corp. | Organogenesis Holdings Inc. | 1,048,691 | 0.8% | EDGAR |
SC 13D/A | 2021-05-11 | Ades Alan A. | Organogenesis Holdings Inc. | 30,263,246 | 23.6% | EDGAR |
SC 13D/A | 2020-11-19 | Avista Acquisition Corp. | Organogenesis Holdings Inc. | 1,048,691 | 0.8% | EDGAR |
SC 13D/A | 2020-11-19 | Ades Alan A. | Organogenesis Holdings Inc. | 44,962,394 | 35.2% | EDGAR |
SC 13G/A | 2020-02-13 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Organogenesis Holdings Inc. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-11-27 | Avista Acquisition Corp. | Organogenesis Holdings Inc. | 1,048,691 | 1.0% | EDGAR |